About MDxHealth S.A.
https://mdxhealth.comMDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally.
CEO
Michael K. McGarrity
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2023-11-14 | Reverse | 1:10 |
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
BLEICHROEDER LP
Shares:7.38M
Value:$26.34M
AWM INVESTMENT COMPANY, INC.
Shares:5.22M
Value:$18.64M
MVM PARTNERS, LLC
Shares:4.7M
Value:$16.78M
Summary
Showing Top 3 of 44
About MDxHealth S.A.
https://mdxhealth.comMDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2025 | $53.21M | $38.97M | $-14.74M | -27.71% | $-0.3 | $700K |
| Q2-2025 | $53.21M ▲ | $38.97M ▲ | $-14.74M ▼ | -27.71% ▲ | $-0.3 ▼ | $700K ▲ |
| Q1-2025 | $24.29M ▼ | $20.09M ▼ | $-9.21M ▲ | -37.91% ▼ | $-0.19 ▲ | $-1.65M ▲ |
| Q4-2024 | $48.06M ▲ | $40.49M ▲ | $-18.03M ▼ | -37.52% ▲ | $-0.54 ▼ | $-6.16M ▼ |
| Q3-2024 | $23.32M | $20.37M | $-11.19M | -47.99% | $-0.4 | $-3.75M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $32.01M ▼ | $154.28M ▲ | $162.54M ▲ | $-8.26M ▼ |
| Q2-2025 | $32.81M ▼ | $140.63M ▼ | $141.52M ▼ | $-883K ▼ |
| Q1-2025 | $65.67M ▲ | $174.83M ▲ | $168.87M ▲ | $5.97M ▼ |
| Q4-2024 | $46.8M ▼ | $157.33M ▼ | $142.49M ▲ | $14.84M ▼ |
| Q3-2024 | $49.27M | $157.41M | $140.41M | $16.99M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2025 | $-3.83M | $-1.6M | $-19.59M | $-11.69M | $-32.86M | $-1.96M |
| Q2-2025 | $-3.83M ▲ | $-1.6M ▲ | $-19.59M ▼ | $-11.69M ▼ | $-32.86M ▼ | $-1.96M ▲ |
| Q1-2025 | $-9.21M ▲ | $-4.1M ▲ | $-476K ▼ | $23.45M ▼ | $18.87M ▲ | $-4.58M ▲ |
| Q4-2024 | $-10.7M ▼ | $-8.74M ▼ | $-242K ▼ | $34.44M ▲ | $-2.47M ▼ | $-9.14M ▼ |
| Q3-2024 | $-6.09M | $-5.62M | $-13K | $33.55M | $27.93M | $-5.83M |
CEO
Michael K. McGarrity
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2023-11-14 | Reverse | 1:10 |
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
BLEICHROEDER LP
Shares:7.38M
Value:$26.34M
AWM INVESTMENT COMPANY, INC.
Shares:5.22M
Value:$18.64M
MVM PARTNERS, LLC
Shares:4.7M
Value:$16.78M
Summary
Showing Top 3 of 44